ESC 2017 Archives - Cardiovascular News

ESC 2017: Further decreasing mortality after STEMI will be difficult

14th September 2017

According to results ...

ESC 2017: Post-TAVI clinical leaflet thrombosis is “infrequently reported” but is a serious adverse event

11th September 2017

Of 5,691 adverse even...

ESC 2017: More evidence that supplemental oxygen in normoxic patients with suspected myocardial infarction does not provide benefit

11th September 2017

Data from DET02X-AMI ...

ESC 2017: Alternative strategies needed for treating stenotic lesions in saphenous vein grafts

7th September 2017

The recent DIVA (Drug...

ESC 2017: CABG is the “preferred strategy” for multivessel revascularisation in patients with type 1 diabetes

7th September 2017

Data from a nationwide ob...

ESC 2017: Young cardiologists discuss highlights of congress

4th September 2017

In this video from the Eu...

ESC 2017: MobiusHD implant shown to reduce resistant hypertension

4th September 2017

The European results ...

ESC 2017: Rivaroxaban significantly lowers risk of stroke, cardiovascular death, and myocardial infarction in patients with coronary artery disease

4th September 2017

The COMPASS study, wh...

ESC 2017: Subanalysis of PEGASUS shows ticagrelor reduces cardiovascular death by 29% in patients with prior myocardial infarction

4th September 2017

A new subanalysis fro...

ESC 2017: Hexacath’s titanium-nitride-oxide coated stent matches Boston Scientific’s Synergy for acute coronary syndrome

1st September 2017

During a late-breakin...

ESC 2017: Best-practice PCI outperforms conventional PCI in patients with de novo three-vessel disease

1st September 2017

The SYNTAX II study h...

ESC 2017: SPYRAL HTN-OFF MED provides “proof of principle” that renal denervation works

1st September 2017

Results from SPYRAL H...

ESC 2017: Significantly lower event rates with Orsiro than with Xience

1st September 2017

Results fro...

ESC 2017: Case builds for dropping aspirin from triple therapy in atrial fibrillation patients post PCI

1st September 2017

The RE-DUAL PCI trial...

Write to us
Editorial: Will Date will@bibamedical.com
Advertising: Hannah Shiels hannah@bibamedical.com

BIBA Medical, Europe
526 Fulham Road, Fulham, London, SW6 5NR
TEL: +44 (0)20 7736 8788
Email: info@bibamedical.com

Terms and Conditions | Privacy Policy